SCHEDULE OF WARRANTS OUTSTANDING (Details) - Warrant [Member] - USD ($) |
6 Months Ended | 12 Months Ended |
|---|---|---|
Jun. 30, 2023 |
Dec. 31, 2022 |
|
| Number of Shares, Warrants Outstanding Beginning | 952,638 | |
| Weighted-Average Exercise Price, Outstanding Beginning | $ 37.60 | |
| Weighted Average Remaining Contractual Life (Years), Outstanding, Ending | 2 years 8 months 4 days | 3 years 6 months 21 days |
| Aggregate Intrinsic Value Outstanding Beginning | ||
| Number of Shares, Warrants Outstanding Beginning | ||
| Weighted-Average Exercise Price, Outstanding Beginning | ||
| Number of Shares, Warrants Outstanding Beginning | (834) | |
| Weighted-Average Exercise Price, Outstanding Beginning | $ 13.60 | |
| Number of Shares, Warrants Outstanding Beginning | ||
| Weighted-Average Exercise Price, Outstanding Beginning | ||
| Number of Shares, Warrants Outstanding Beginning | 951,804 | 952,638 |
| Weighted-Average Exercise Price, Outstanding Beginning | $ 32.80 | $ 37.60 |
| Aggregate Intrinsic Value Outstanding Beginning |
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments non option outstanding weighted average remaining contractual terms ending. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which non-option equity holders acquired shares when converting their non-option equity into shares. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which non-option equity holders acquired shares when warrants forfeited. No definition available.
|
| X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of non-option equity. No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock non-option equity plan. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award equity instruments non option aggregate intrinsic value non vested. No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|